Term ends Sep 26, 2028 · Medium confidence
20-year base term ends Sep 26, 2028
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 8,455,439, US 8,455,441, US 8,889,129, US 9,056,106, US 9,062,298), so the cap could be lower.
Sep 26, 2008
Sep 26, 2028
Jul 12, 2016
This patent's term runs 16 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 26, 2008, when application 12/239,651, the earliest non-provisional in its chain, was filed (this one was filed Jul 21, 2014) | Sep 26, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +16 days, USPTO patent term adjustment record | Oct 12, 2028 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,153,590, US 8,268,783, US 8,455,439, US 8,455,441, US 8,889,129, US 9,056,106, US 9,062,298, US 9,109,046) | capped to Sep 26, 2028 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 26, 2028 | Medium confidence |
This family
| US 8,153,590 | In force Jan 2034 | Jan 2034 |
| US 8,268,783 | In force Feb 2029 | Feb 2029 |
| US 8,455,441 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 9,109,046 | In force Jan 2029 | Jan 2029 |
| US 9,062,298 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 8,889,129 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 9,388,401 | this patent Sep 2028 | Sep 2028 |
| US 9,587,233 | In force Sep 2028 | Sep 2028 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 22, 2014 Reel 33364, frame 309 | Lu, Genmin; Phillips, David R.; Andre, Patrick; Sinha, Uma | Portola Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Mar 18, 2019 Reel 48633, frame 673 | Portola Pharmaceuticals, Inc. | HCR Collateral Management, LLC | Security Interest |
| Jul 2, 2020 Reel 53120, frame 925 | HCR Collateral Management, LLC | Portola Pharmaceuticals, Inc. | Release of Security Interest |
| Dec 17, 2020 Reel 54795, frame 162 | Portola Pharmaceuticals, Inc. | Portola Pharmaceuticals, LLC | Change of Name |
| Dec 17, 2020 Reel 54795, frame 630 | Portola Pharmaceuticals, LLC | Alexion Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jan 5, 2021 Reel 54899, frame 357 | Portola Pharmaceuticals, Inc. | Portola Pharmaceuticals, LLC | Corrective Assignment to Correct the State of the Assignee Previously Recorded on Reel 054795 Frame 0162. Assignor(S) Hereby Confirms the Change of Name. |
| Feb 17, 2021 Reel 56014, frame 1 | Alexion Pharma International Operations Unlimited Company | Alexion Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Feb 17, 2021 Reel 56392, frame 716 | Alexion Pharmaceuticals, Inc. | Alexion Pharma International Operations Unlimited Company | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 8,153,590, US 8,268,783, US 8,455,439, US 8,455,441, US 8,889,129, US 9,056,106, US 9,062,298, US 9,109,046.